Sep 2, 2026 07:32AM
Aug 20, 2026 09:30AM
Jul 2, 2026 07:34AM
Jun 29, 2026 08:45AM
Jun 17, 2026 08:16AM
Jun 15, 2026 08:05AM
Jun 10, 2026 07:47AM Polyrizon receives European patent publication for nasal drug delivery tech
Jun 8, 2026 09:31AM
May 13, 2026 09:25AM
May 4, 2026 08:45AM
Apr 27, 2026 09:29AM
Apr 7, 2026 08:10AM
Mar 26, 2026 09:24AM
Mar 10, 2026 07:56AM Polyrizon completes GMP manufacturing for planned US clinical trial
Feb 26, 2026 08:13AM
Feb 19, 2026 04:15PM
Feb 10, 2026 06:55AM
Feb 9, 2026 08:00AM
Feb 6, 2026 08:02AM
Feb 6, 2026 07:57AM
Jan 22, 2026 09:25AM Polyrizon begins usability study for NASARIX allergy blocker
Jan 13, 2026 08:39AM
Jan 8, 2026 08:46AM
Jan 5, 2026 09:07AM
Jan 2, 2026 08:32AM
Dec 29, 2025 07:20AM
Dec 11, 2025 08:16AM
Dec 8, 2025 08:56AM Polyrizon completes FDA pre-submission meeting for PL-14 nasal spray
Dec 3, 2025 09:29AM
Dec 2, 2025 07:55AM
Nov 7, 2025 04:18PM
Nov 6, 2025 08:55AM
Oct 6, 2025 08:21AM
Sep 19, 2025 08:15AM
Sep 12, 2025 07:26AM Polyrizon reports successful nasal delivery of allergy blocker in study
Jul 22, 2025 08:32AM
Jul 15, 2025 07:55AM
Jun 12, 2025 07:32AM
May 23, 2025 04:17PM
May 13, 2025 07:45AM
Apr 25, 2025 07:37AM
Apr 2, 2025 09:06AM Polyrizon (PLRZ) Engages Leading Branding Firm for Strategic Brand Development
Apr 1, 2025 04:09PM
Mar 31, 2025 09:33AM
Mar 27, 2025 08:25AM
Mar 25, 2025 04:04PM
Mar 19, 2025 07:37AM
Mar 14, 2025 08:36AM
Mar 13, 2025 07:51AM Polyrizon (PLRZ) Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Mar 10, 2025 07:48AM

448,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All